Literature DB >> 2161748

Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s.

T Aoyama1, K Korzekwa, K Nagata, J Gillette, H V Gelboin, F J Gonzalez.   

Abstract

Twelve forms of human cytochrome P450 were synthesized in human hepatoma Hep G2 cells by means of cDNA-directed expression using vaccinia virus. The cDNA-expressed enzymes were tested for their ability to oxidize estradiol. Incubation of [14C]estradiol with cell lysates containing P450 IA2 resulted in the production of 2-hydroxy and 4-hydroxy metabolites with substrate turnovers of 2.74 and 0.27 min-1, respectively. P450s IIIA3 and IIIA4 yielded the same metabolites at about one third the rate of P450 IA2. Low levels of estradiol hydroxylation were also catalyzed by P450s IIC9, IIIA5, and IVB1. Six other P450 forms yielded no detectable metabolism. The roles of P450s IA2, IIA3, and IIIA4 were further established by immunoinhibition using antirat P450 antibodies. Antibody that specifically binds to P450 IIIA3 and IIIA4 inhibited 60-70% of estradiol hydroxylation, and antibody against P450 IA2 inhibited 20-40% of the estradiol hydroxylase activity in microsomes from two human liver specimens, suggesting that these enzymes constitute the major forms catalyzing estradiol oxidation in human liver. Immunoinhibition results also suggest that 2-hydroxy- and/or 4-hydroxycatechol estrogens are further metabolized to other yet uncharacterized metabolites by P450s IIIA3 and IIIA4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161748     DOI: 10.1210/endo-126-6-3101

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Cytochrome P450 family 4 in a cockroach: molecular cloning and regulation by regulation by hypertrehalosemic hormone.

Authors:  J Y Bradfield; Y H Lee; L L Keeley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.

Authors:  L M Forrester; C J Henderson; M J Glancey; D J Back; B K Park; S E Ball; N R Kitteringham; A W McLaren; J S Miles; P Skett
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

Review 3.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

4.  Establishment of a human hepatoma cell line, HLE/2E1, suitable for detection of p450 2E1-related cytotoxicity.

Authors:  I Nozaki; T Tsuji; M Sakaguchi; Y Inoue; R Hirai; A Andou; M Miyazaki; N Shimizu; M Namba
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-10       Impact factor: 2.416

5.  Induction of cytochrome P450 1A1 in MCF-7 human breast cancer cells by 4-chlorobiphenyl (PCB3) and the effects of its hydroxylated metabolites on cellular apoptosis.

Authors:  Anna Ptak; Gabriele Ludewig; Agnieszka Rak; Weronika Nadolna; Michał Bochenek; Ewa L Gregoraszczuk
Journal:  Environ Int       Date:  2009-07-14       Impact factor: 9.621

6.  In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.

Authors:  D J Birkett; D Rees; T Andersson; F J Gonzalez; J O Miners; M E Veronese
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

7.  Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 1A2.

Authors:  T Pineau; P Fernandez-Salguero; S S Lee; T McPhail; J M Ward; F J Gonzalez
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.

Authors:  C L Hayes; D C Spink; B C Spink; J Q Cao; N J Walker; T R Sutter
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma.

Authors:  Mostafizur Rahman; Sigurd F Lax; Carrie H Sutter; Quynh T Tran; Gaylene L Stevens; Gary L Emmert; Jose Russo; Richard J Santen; Thomas R Sutter
Journal:  Drug Metab Dispos       Date:  2008-02-06       Impact factor: 3.922

10.  The Role of Human Aldo-Keto Reductases in the Metabolic Activation and Detoxication of Polycyclic Aromatic Hydrocarbons: Interconversion of PAH Catechols and PAH o-Quinones.

Authors:  Li Zhang; Yi Jin; Meng Huang; Trevor M Penning
Journal:  Front Pharmacol       Date:  2012-11-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.